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Summary Secular and cohort trends in mortality from cancer in Scotland during 1953-93, and incidence during 1960-90, were analysed using
individual records from the national mortality and registration files. For certain cancer sites, the secular analyses of mortality were extended
back to 1911 by use of published data. Mortality from cancer at older ages in Scotland has increased over the last 40 years. In each sex, this
trend has been dominated by the effects of smoking: all-cancer rates and rates of lung cancer, now the most common fatal cancer in men and
in women in Scotland, reached a peak in the cohort of men born at the turn of the century and the cohort of women born in the 1920s. For much
of the period, the Scottish all-age rates of lung cancer were the highest reported in the world; they are now decreasing on a secular basis in
men, but are still increasing in women. There have also been large increases at older ages in the incidence and mortality rates for cancer ofthe
prostate in recent years, bladder cancer, nervous system cancer, non-Hodgkin's lymphoma, myeloma and leukaemia; for each there is likely to
be a considerable artefactual element to the increase, with differing degrees of possibility that there may in addition be an element of real
increase. Substantial decreases in mortality at all ages have occurred for stomach and colorectal cancers and substantial increases at all ages
for pleural cancer and melanoma. Rates of mortality from breast cancer, the most common cancer in women in Scotland, have generally
increased over the past 80 years; a temporary cessation in this upward trend occurred in the years during and after the Second World War, and
recently rates have turned downward, probably at least in part because of better treatment. Mortality from ovarian cancer, the second most
common reproductive-related female tumour in Scotland, has also increased at older ages. At younger ages, mortality from cancer in Scotland
has decreased, especially in men, whereas incidence has not. This divergence, which has been a consequence of better treatment, has
occurred especially for cancers of the testis and ovary, Hodgkin's disease and leukaemia. There have been increases at young adult ages,
however, in both mortality from and incidence of oral and pharyngeal, oesophageal and laryngeal cancers in men, and melanoma and non-
Hodgkin's lymphoma in each sex. Cervical cancer rates at young ages also increased, but this trend has reversed for incidence in the most
recent birth cohorts. Incidence rates have also increased for testicular cancer in young adults and leukaemia in children. With the possible
exceptions of non-Hodgkin's lymphoma and childhood leukaemia, the increasing rates are likely largely to reflect real rises in incidence, and
they highlight the need for investigation of the causes of these cancers, and, when causes are known, for preventive action.
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Trends in cancer incidence and mortality are of interest both for
epidemiology and for clinical and public health planning, but data
on these trends are often difficult to access for those outside (and
sometimes inside) the country concerned. Scotland has a long
tradition of medical care and innovation in oncology including, for
instance, the introduction of oophorectomy for treatment of breast
cancer by Beatson (1896), and the description of naevi as a risk
factor for melanoma by Norris (1820). Data about cancer inci-
dence and mortality in Scotland have been collected for several
decades, but the resulting information has mainly been published
in locally circulated printouts and single-year volumes of official
statistics, or occasional research papers on particular tumours.
Some data on cancer mortality from 1975-88 (Coleman et al,
1993) and 1955-89 (La Vecchia et al, 1992; Levi et al, 1992) and
incidence 1973-87 (Coleman et al, 1993) have been published as
part of overviews of international cancer trends, but without
Received 16 July 1997
Revised 27January 1998
Accepted 27January 1998
Correspondence to: AJ Swerdlow
consideration oftrends in risk factors in Scotland in relation to the
cancer trends or of possible artefacts in Scottish data. Cancer
survival data for Scotland from 1968-90 have been published by
Black et al (1993).
Scotland has a population of 5 million, most of whom live in a
heavily industrialized belt across the centre ofthe country, and the
remainder in the relatively sparsely populated areas to the south
and north of this. The geographical distribution of cancer inci-
dence in the country has been described in detail, although for a
fairly short period, by Kemp et al (1985), and the geography of
cancer mortality, again for a small number of years, has been
shown in Smans et al (1992). The present supplement describes
site-specific trends in cancer incidence in Scotland for the last 30
years, and mortality in detail for a 40-year span and in less detail
for a few sites over the past 80 years. By analysing data based on
individual mortality records since 1953 and incidence records
since 1960, we were able to conduct new analyses, beyond those
previously published, especially with respect to risks by birth
cohort based on actual year of birth. This supplement presents
trends for 22 cancer sites, selected because they are particularly
common or their trends are of particular interest. The cancers are
presented in the order of their codes in the International2 AJ Swerdlow etal
Classification of Diseases (WHO, 1978). We have presented the
material for mortality before that for incidence for each site, and
for sites with poor survival we have often presented as Figures
only the mortality data, because these are available for a longer
period and are less likely to be affected by changes in complete-
ness over time than are the incidence data.
For sites such as testis, melanoma and Hodgkin's disease,
however, where survival is good, incidence trends are of greater
interest and have therefore been given more emphasis. It should
also be noted that data on trends at middle and younger ages are
likely to be more reliable than those for older ages (Grulich et al,
1995), although the high rates of cancer at older ages make these
important to consider too from a public health and health care
perspective.
MATERIALS AND METHODS
Cause-specific mortality data have been published for Scotland
since 1855, although the first year for which cancers were tabu-
lated by site was 1901 (Registrar General in Scotland, 1904).
Individual records for cancer deaths since 1953 are held on
computer, and the present supplement mainly concerns the years
since then (1953-93), for which we analysed trends using these
records. For selected malignancies, however, in order to consider
changes over a longer period, we also used published annual
mortality data back to 1911, which have been aggregated by
Division of Epidemiology (1976). From this source we extracted
rates for 1911-54, andjoined these with the rates for 1955-93 that
we had calculated from the computer files.
Cancer registration in Scotland started in 1936 with a system
initiated by the Radium Commission, and was organized into a
national scheme in 1959. There are five Regional Registries submit-
ting a common data set to the Information and Statistics Division of
the Scottish Health Services Common Services Agency, which
produces national files and analyses. The data covered in the
present publication are those for cancers incident from 1960-90.
Further details on each of the Scottish registries and their methods
ofdata collection can be found in Parkin et al (1992).
Data were extracted from national computer files on all deaths
coded to the underlying cause malignant neoplasm occurring in
Scotland in 1953-93 in residents of the country. Non-melanoma
skin cancers were excluded from the analyses to give compara-
bility with the incidence data (see below). Population data to
provide denominators for calculating rates were obtained from the
General Register Office for Scotland.
Age-standardized mortality rates were calculated for 1953-54,
1990-93 and the five-year periods in between, standardizing
directly by single year of age to the Scottish population of 1971.
These rates were calculated for the age groups 0-14, 15-34,
35-49, 50-69 and 70-84 years. We did not calculate rates for age
85 years and above, because information on cause ofdeath at these
ages is likely to be unreliable. When few cases of a particular
malignancy occurred at an age group (usually ages 0-14 and/or
15-34 years), and rates were consequently unstable, we omitted
this age group from the Figures displaying the results. We have
nevertheless presented the data for each adult age-group (and 0-14
years when of interest) in the tables of results. For leukaemia at
young ages we also examined trends with a finer age breakdown.
For each time period, we calculated the age-standardized rate in
each age group as a percentage of the age-standardized rate in the
same age group in 1953-54. For most of the cancer sites these
percentages rather than the actual rates have been presented in the
Figures as they give a much clearer picture of changes over time.
Cancers were coded in the mortality files to the Sixth Revision
of the International Classification of Diseases (ICD6) for
1951-57, ICD7 for 1958-67, ICD8 for 1968-78, and ICD9 for
1979 onwards. We bridge-coded these data to ICD9 categories
(WHO, 1978) for analysis. The ICD coding before the Seventh
Revision does not allow separation of lung and pleural cancers, so
we analysed data for these separately only for 1958 onwards; for
examination of longer term trends we combined the sites.
For the years 1911-54, the data in the published material (Division
of Epidemiology, 1976) were already bridge-coded to ICD8, so we
simply reassigned these to the appropriate ICD9 categories.
To analyse cancer trends in relation to birth cohort, we used the
date of birth information in the original individual records to
calculate age-specific mortality rates by actual year of birth, rather
than the quinary quinquennial estimates by the method of Case
(1956) that are usually used. From the age-specific rates we then
calculated age-standardized cohort mortality ratios (SCMRs)
(Beral, 1974), generally for quinquennial periods of birth, but also
by single year of birth when this was of interest. The SCMRs
provide a summary measure of the risk in each birth cohort (gener-
ation), at the ages they had reached in the study period, relative to
mortality at the same ages for all cohorts included in the analysis,
with adjustment for differences in age structure.
Cancer incidence trends were analysed similarly to those for
mortality, but for the shorter period for which data were available
(1960-90). The ICD coding for cancer incidence was the same as
that for mortality except that the first year in which ICD9 was used
for incidence was 1980. We omitted non-melanoma skin cancers
from the analyses because their registration is known to be highly
imperfect and their large numbers might otherwise influence arte-
factually the totals for malignancies overall.
We present the results of the analyses as Figures, and as Tables
of the data underlying these Figures. Although we have
commented in the text on both secular and cohort trends in inci-
dence and mortality for each cancer site analysed, for reasons of
space we have been selective in presentation of the trends in the
Figures. Similarly, to save space the Tables show data only for
selected calendar periods: the full results in tabular form can be
obtained from the authors.
Completeness and accuracy of data, and possible
artefacts
Possible incompleteness of cancer registration, and changes in the
extent of this incompleteness, are of concern in interpretation of
recorded incidence trends. There is little direct information avail-
able on the completeness of national registration in Scotland. A
study collecting data independently from several hospital sources
on childhood leukaemia in Scotland from 1968-81 found registra-
tion to be 99% complete, with 0.5% duplication and 1% of regis-
tered cases not in fact leukaemia (Glass et al, 1987). It might well
be the case, however, that registration was better than average for
this malignancy at an age when cancer is a particularly noteworthy
event.
Information on accuracy of Scottish national cancer registration
data is available only for 1990 (Brewster et al, 1994), the last year of
incidence included in this Supplement. Reabstraction of data for
over 2000 cases in that year showed a good level of accuracy, with
5% ofcases coded to the wrong ICD code, and 2.8% ofregistrations
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Table 1 Percentage of cancer registrationsa with histological confirmation and percentage registered from death certificate only,
Scotland, 1960-4 to 1985-9
Age (years) Per cent histologically verified Per cent registered from death
sex certificate only
1960-4 1985-9 1960-4 1985-9
0-14
Males 90.9 91.2 0.3 0.0
Females 89.2 91.4 0.7 0.0
15-34
Males 87.2 93.0 0.0 0.2
Females 84.8 94.1 0.4 0.4
35-64
Males 73.4 81.9 1.2 2.5
Females 84.6 87.0 1.1 1.9
65-84
Males 61.8 69.5 3.7 4.6
Females 70.3 70.3 3.9 4.6
aAll malignancies except non-melanoma skin cancer.
that should not have been registered as malignancies in that or
adjacent years.
The proportion ofregistered malignancies in Scotland for which
histological confirmation was available has been high, except at
older ages, and has changed little or increased slightly from 1960
to 1989 (Table 1). The percentage registered only from death
certificates has been low, except at ages 85 and above, and has
tended to increase slightly at age 35-84 years (Table 1).
Mortality data in Scotland are probably virtually complete for
the fact of death, and even in the early part of the century almost
all deaths had the cause certified by a qualified person: in 1911,
1.6% were not certified by a registered medical practitioner or
Procurator Fiscal, from 1922 onwards under 1% (RG for Scotland,
1931) and by 1936, 0.3% (RG for Scotland, 1937); since about
1956, all deaths have been certified by a registered medical practi-
tioner. This does not mean, of course, that all cancer deaths are
necessarily certified as such. In a study of 1152 post-mortems in
the Lothian region ofScotland in 1975-77, autopsy made virtually
no difference to the total number ofcancers diagnosed clinically in
the patients (Cameron and McGoogan, 1981a), but did reveal
appreciable under- or overdiagnosis for certain cancers - specifi-
cally, among sites covered in this Supplement, underdiagnosis of
malignancies of the lung, stomach, bladder and nervous system,
and non-Hodgkin's lymphoma (Cameron and McGoogan, 1981b).
There has been an improvement in general precision of diagnosis
of cause of death in Scotland over time, which may have led to
some artefactual increase in cancer rates, especially at older ages.
Thus, for instance, mortality from senility without mention of
psychosis has decreased from 4.9% of all deaths in 1911 (RG
Scotland, 1914) to 1.4% in 1953 (RG for Scotland, 1961) and
0.1% in 1990 (RG Scotland, 1991). Mortality from signs, symp-
toms and ill-defined causes decreased from 2.7% of all deaths in
1953 to 0.6% in 1993. (No comparable data exist for 1911).
For several decades at least, 'medical enquiries' have been
made by the Registrar General for Scotland to certifiers of deaths
when the cause described on the certificate was insufficiently
precise. Changes in such enquiry practice could alter rates for
imprecise categories (Swerdlow, 1989). As far as we can ascertain,
however, no substantial changes in enquiry practice were made
during the study period, at least as far back as the early 1970s.
Methods of data collection and changes in ICD coding can also
potentially lead to artefacts. Two changes in the registration
system that might have affected completeness are that in 1968
input to the registries of computerized lists ofhospital admissions
was started, and from 1975 registrations were accepted when only
death certificate information about the cancer, unsupported by
other evidence, was available.
To examine whether sudden artefactual changes in cancer rates
might have occurred as a consequence ofchanges in data collection
methods or ICD revision, we analysed incidence and mortality rates
for all cancers, and forcancers ofunspecified site, by single calendar
year (Figures 1 and 2). For incidence, these data showed in each sex
a sudden peak in rates of cancer ofunspecified site in 1966-7, with
rates subsequently returning to theirprevious level. This pattern was
present at each age (not shown in Figure). A lesser increase at the
same dates was seen for all-cancer incidence, rates ofwhich did not
return subsequently to their previous level. No peak was present in
1966-67 for mortality. The peak in registration rates in 1966-67
may have occurred because hospital admissions in early 1968, when
data on these admissions were first input to cancer registration
nationally in Scotland, would mainly have related to patients with
cancers incident in the year or two before the admission. Some of
these notifications, especially when the site of cancer was not
known, may not have been linked to registrations already made for
those years, and hence may have been reregistered. By the time that
data for 1968 itself were registered, however, mechanisms to avoid
duplicate registration may have become established (but some more
modest, long-term increase in overall registrations may have
occurred from cancers found solely from this new source).
Incidence data for all cancers showed a sudden, but sustained,
increase in rates in 1975 for men, and to a lesser extent for women.
This presumably reflects the input of 'death certificate only' cases
to cancer registration from that year. No such increase occurred for
cancer ofunspecified site, or in mortality data.
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Figure 2 shows one other feature likely to reflect incomplete-
ness. From 1960 to 1966, the incidence of all cancers in men was
almost the same as the mortality rate. Although the lag between
cancer incidence and mortality makes it possible for contemporary
rates of the two to be similar when incidence rates are falling fast,
Scottish rates were not falling at this time, and it is not plausible
that cancer was the cause of death in virtually all men in whom it
occurred. Thus it seems likely that the Scottish registration data
were substantially incomplete before 1967, and presumably this
was true in women too (for whom there was also a rise in rates in
1966-67).
In summary, Scottish cancer registration data were probably
substantially incomplete before 1967, with long-term improve-
ments in 1966-67 and further in 1975. A large artefactual increase
in rates of cancer ofunspecified site occurred temporarily for inci-
dence in 1966-67, but if this was due to duplicate registrations, it
should not have inversely affected rates of cancers of known site.
There has been a continuing rise in mortality from cancers of
unknown site through the last 40 years, which may have dimin-
ished artefactually the rates of cancers of known site.
Two further potential artefacts need consideration in relation to
the mortality trends. Firstly, for the early data, the adoption of the
fifth revision of the ICD in 1941 altered the rules for selection of
underlying cause of death from the use ofarbitrary rules ofprece-
dence to a method taking account of the order of causes written on
the certificate. The effect of this change on cancer trends appears
to have been slight - under I % for cancer overall in double-coded
data (Registrar General for Scotland, 1942). Secondly, it should be
noted that the change in interpretation of rule 3 ofthe ICD that was
implemented in England and Wales in 1984 (OPCS, 1985), and
which led to a considerable artefact in English and Welsh trends,
was not implemented in Scotland.
RESULTS AND DISCUSSION
All malignancies (Figure 3)
Cancer mortality rates in Scotland have increased at older ages but
decreased at younger ages. In men aged under 50, a decrease of a
third or more occurred since 1970, and in boys a decrease of a half
since 1960. Decreases have occurred in females under 50, but less
marked than those in males. Incidence rates have increased at all
adult ages in each sex, most greatly at age 70-84 years and least at
age 35-49 years. In children, incidence rates increased by about a
third, mainly in the last 15 years.
Analysed by birth cohort, mortality reached a peak in the cohort
of men born in 1900-04, and of women born in 1920-24, and then
declined. Incidence increased in cohorts born up to about 1910-14
in men and 1920-24 in women, but there has not been a marked
trend since, except for a rise in recent cohorts of males.
The increase in recorded mortality from cancer at older ages in
Scotland is similar to that seen in many Western countries. In part
it probably reflects better diagnosis of certain solid malignancies
and of lymphohaematopoietic malignancies, but also there appear
to have been real increases in mortality from cancers of several
sites, discussed below. The decreases in cancer mortality at
younger ages are due primarily to much improved survival for
certain cancers as a result of better treatment. Five-year survival
for all malignancies at ages 25-34 years improved from 55.2% for
cancers incident in 1968-72 to 69.9% for those incident in
1983-87; there was a similar improvement at ages 15-24 years,
and greater improvements in children - from 37.9% to 62.4% at
ages 5-14 years, and 32.5% to 68.8% at ages 0-4 years (Black et
al, 1993).
The increases recorded for cancer incidence in part reflect
greater incidence of certain malignancies, as discussed below, but
may also reflect greater diagnosis and completeness of registra-
tion, changes in criteria for distinction between malignant and
benign neoplasms.
Cancers of the tongue, mouth and pharynx (Figure 4)
We have grouped for analysis, those cancers of the tongue, mouth
and pharynx that are coded in ICD9 to codes 141, 143-6 and
148-9; these are largely of squamous cell histology, and share
similar epidemiological characteristics. We have not included
malignancies of the lip, salivary glands and nasopharynx, which
have distinctive epidemiologies differing from that of the
remainder of the mouth and pharynx.
Trends in oral and pharyngeal cancer mortality in men have
varied greatly by age. At age 70-84 years, the mortality rate has
decreased by three quarters in the last 40 years; at 50-69 years, the
rate diminished to about a half, and then more than regained its
original level; in contrast at age 35-49 years, the rate has more
than quadrupled since 1970-74. The pattern is different in women,
in whom rates at age 35-49 years have more than halved since
1953, at age 70-84 years have decreased and at 50-69 years
increased. Data on incidence (not shown in Figure 4) display a
similar pattern. In particular, the large increase in rates in young
men but not women since 1970 for mortality is present also for
incidence.
Cohort mortality data show that the secular increase in oral and
pharyngeal cancer rates in young men reflects increases between
the cohorts born from 1910-15 to 1945-49. In women the
decrease at young ages occurred mainly in cohorts born from
1930-34 to 1945-49. The cohort data also reveal a further point,
however: in men born after 1949 there has been a reversal of the
upward trend, with decreasing rates in successive cohorts. There
have been few deaths in women born after 1949. In cohort data for
incidence (not shown) there was a similar pattern to that for
mortality.
The trends in oropharyngeal cancer are likely to be due
primarily to changes in alcohol consumption and smoking, since
these are the main risk factors in Western populations. Large
increases in oropharyngeal cancer rates in men have been seen in
several Western countries (Blot et al, 1994). The trend of most
concern in Scotland is the large increase in young men; the
decreasing lung cancer mortality in the same group in recent years
implies, however, that smoking has decreased, on average, in this
population, and this accords with available smoking data - from
1975 to 1990, the proportion of men aged 16-24 who were
smokers diminished from 41% to 28%, and there were decreases at
other young adult ages too (ISD, 1993). Thus, the oropharyngeal
cancer trend seems likely to reflect changes in drinking and/or in
the proportion of heavy drinkers and smokers in the male popula-
tion. We do not have data on alcohol consumption trends sepa-
rately by sex, or indeed for Scotland separately from the rest ofthe
UK, but for the UK overall alcohol consumption per capita has
increased greatly since 1950 (Spring and Buss, 1977). Data on
alcohol-related deaths in Scotland since 1970 (not available by
age) show large increases in each sex: totalling psychiatric,
hepatic, cardiac and accidental violent deaths stated to be due to
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alcohol, crude rates increased fivefold in men and sevenfold in
women (Scottish Council on Alcohol, 1997), and alcoholic liver
disease death rates increased about tenfold in each sex, although it
is likely that in part, at least, this reflects changes in certification
practice, for instance with regard to the acceptability of
mentioning alcohol on a death certificate. In several other coun-
tries, oral and pharyngeal cancer trends have correlated better with
changes in alcohol than tobacco consumption (Blot et al, 1994).
Smokeless tobacco use in Scotland is low, but a small number of
the tumours, and perhaps a small part of the increase in rates, were
due to betel quid chewing in the Indian subcontinent origin popu-
lation of Scotland (Matheson et al, 1985). Nutritional factors,
especially fresh fruit and vegetable consumption, may be protec-
tive against oral and pharyngeal cancers, but, except for a
declining intake of potatoes, these have remained stable over the
period for which data are available (since 1953), (see below, this
page), although there may well have been improvements, in
seasonal availability at least, before then.
Cancer of the oesophagus (Figure 5)
In men, oesophageal cancer mortality rates have been increasing at
younger ages for the last 40 years and at older ages in more recent
years. In women, too, there have been increases at older ages in the
last 20 years or so, but there has not been an increase at ages under
50 years. Incidence data (not shown) confirm these trends for the
years since 1960.
Cohort mortality data show that the increase in men started with
the birth cohort of 1895-99 and probably ceased with that of
1935-39. In women, the rates increased from cohorts born before
the turn of the century to those born in 1915-19, and have since
diminished slightly. In incidence data by cohort (not shown) there
was a similar pattern.
Mortality data for 1911 onwards set the recent rise in
oesophageal cancer rates in Scotland in its historical context. The
low rates in each sex in the early 1960s followed previous peaks of
mortality, in men in the mid-1930s and in women somewhat later.
It is interesting to compare the trends in oesophageal cancer
with those for oral and pharyngeal cancers, for which alcohol and
tobacco are also major aetiological factors. The very large increase
in incidence oforal and pharyngeal cancers in young men in recent
years is not matched by a similar scale of increase in cancer of the
oesophagus. The secular trends in oesophageal cancer are also
very different from those for lung cancer (Figures 10 and 11),
suggesting that smoking is not the dominant reason for the trends:
unlike lung cancer, mortality from oesophageal cancer was about
as great in the 1930s as in the 1960s, and for most of the period
since 1930 the trends for the two tumours have been in opposite
directions. Direct information on tobacco consumption is only
available for Scotland since 1956, and does not obviously accord
with the oesophageal cancer trends (although of course this would
not be pertinent to long lag period effects): from 1956 to 1975
tobacco consumption per adult was unchanged in men and
increased in women (from 3.2 lbs to 5.3 lbs per year) (Lee, 1976);
from 1975 to 1990 data are available in a different form, and show
a decrease in the proportion of adults who were smokers [from
51% to 33% in men, and from 44% to 35% in women (ISD,
1993)]. Alcohol consumption, as noted above (see pp. 4-5), has
probably risen considerably in Scotland since 1950. Deficiency of
fresh fruit and vegetables may also contribute to oesophageal
cancer risk, but apart from decreasing potato consumption, intake
of these does not appear to have diminished appreciably in the last
40 years (see below, this page). A rising incidence of adenocarci-
noma of the oesophagus has been noted in several countries, which
appears not to be due primarily to alcohol intake or smoking (Blot
et al, 1991). We did not have information on the extent to which
the Scottish increase was in these tumours.
Similar increases in oesophageal cancer to those in men in
Scotland have been observed in several other north European
countries excluding Scandinavia, and have also been considered
probably to be due to increasing alcohol consumption, sometimes
despite falling tobacco consumption (Day and Varghese, 1994).
Cancer of the stomach(Figure 6)
Stomach cancer mortality has decreased greatly at all ages in both
sexes over the last 40 years: by 60% in men and by more than 70%
in women. The decreases have been particularly large at young
ages, with rates now about a fifth of those in the early 1950s. In
data for 1911 onwards, these reductions can be seen to be part of a
longer term trend dating back to the 1930s. Incidence data too
show decreases in both sexes and all ages, except men aged 70-84
years, the group with the smallest proportional decrease in
mortality over the same period.
The decrease in stomach cancer mortality in men occurred in
cohorts born from 1880-84 to 1945-49, but not subsequently. The
decrease in women was mainly in cohorts born between 1865-69
and 1915-19, and to a lesser extent up to 1940-44, but not subse-
quently. In incidence data by birth cohort (not shown) too, the
decreasing rates in each sex ceased for those born after the Second
World War.
The decrease in stomach cancer is numerically the largest
beneficial change in the adult cancer mortality rate over the last 40
years, although it cannot be attributed either to deliberate preven-
tive measures or to improvement in survival, which remains poor.
The precise reasons for the decrease are not known. In part, at
least, it is likely to relate to improved food storage - refrigeration,
and less use of pickling, smoking and salting as preservative
measures - and to greater availability of fresh fruit and vegetables
in the diet. The apparent cessation of the decline in rates in the
post-war generations is as yet based on small numbers, but is
present in each sex. Data on fresh fruit and vegetable consumption
in Scotland are available from 1953-84, and show little change for
fresh fruit [16.7 oz per person per week in 1953 (MAFF, 1955),
15.3 oz in 1984 (MAFF, 1986)] or fresh green vegetables (5.6 oz in
1953; 5.4 in 1984) or other vegetables than potatoes (19.3 in 1953,
17.7 in 1984), although potato consumption decreased consider-
ably (72.1 in 1953, 43.2 in 1984). Similarly, vitamin C content of
the diet has been unchanged [47 mg per person per day in 1953; 49
in 1984; 43 in 1995 (MAFF, 1996)]. Data are not available for the
period before 1953, but seasonal availability of fresh fruit and
vegetables, at least, may have improved greatly. The decrease in
stomach cancer may also relate to better social and sanitary condi-
tions in early life, and changes over time in the prevalence of
infection with Helicobacterpylori. There do not appear to be data
on helicobacter trends in Scotland, but in Yorkshire, England,
decreasing seroprevalence has been found between cohorts born in
1910-19 and 1960-69 (Banatvala et al, 1993); the continuing
decrease in post-war cohorts contrasts with the levelling-off of
stomach cancer trends in these generations. Finally, the decline in
stomach cancer may in part be due to a transfer ofdeaths attributed
to stomach cancer to more correctly localized sites.
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Cancers of the colon and rectum (Figure 7)
Mortality from colorectal cancer has decreased by about a third in
each sex over the past 40 years, with reductions in all age groups.
The decrease occurred throughout the period in women, but in
men appears to have ceased since 1980-84. Incidence data,
however, showed a different picture. Although rates have
decreased in women at ages under 35 years, there has been little
change, or an increase, in women at older ages and in men at each
age (except perhaps at ages 15-34 years).
Cohort data showed in each sex a steady decrease in mortality
rates for cohorts born from the 1870s through to 1960-64. For inci-
dence, there was in each sex an increase for cohorts born up to the
mid-1920s, and then a small decrease for those born subsequently.
The divergence between incidence and mortality trends for
colorectal cancer mainly reflects improved survival, although it is
not clear if this can fully explain it: all ages 5-year survival
increased from 25.4% for cases diagnosed in 1968-72 to 30.1%
for those diagnosed in 1983-87, with greater increases at younger
ages - for instance from 33.6% to 46.7% at ages 35-44 years
(Black et al, 1993). The improved survival may reflect earlier
diagnosis and improvements in surgery (Ries, 1994).
The reasons for the changes in incidence are unclear: a large range
of factors have been suggested as potentially affecting colorectal
cancer risk - aspects of diet (including saturated fats, dietary fibre
and brassica vegetables), alcohol consumption, sedentariness, chole-
cystectomy, sex hormones and non-steroidal anti-inflammatory
drugs - but there is insufficient information on which are of substan-
tial aetiological or preventive effect, and on their trends in Scotland,
to assess the reason for the incidence trends. It is probable that
dietary factors play a large role, and hence that changes in diet are at
least partly responsible for the trend. One factor that will have
contributed to trends at young ages is the preventive effect of
improved detection and treatment of familial polyposis coli.
Cancer of the pancreas (Figure 8)
Mortality rates from cancer of the pancreas increased at all ages
over 35 years until about 1970, but subsequently there was a
decline in men and no clear trend in women. In incidence data for
men (not shown) there was a similar pattern to that for mortality,
but in women there was an appreciable increase since 1960 not
seen for mortality.
Mortality data showed no great change between cohorts, but in
the most recent cohorts, trends were irregular and confidence
intervals wide. There was a small peak in men born in 1900-4 and
women born in 1925-29. In incidence data by birth cohort (not
shown) there was a similar pattern.
Since the prognosis of cancer of the pancreas is very poor [5-
year survival remains under 5% (Black et al, 1993)], incidence and
mortality trends for the tumour should be almost identical. For
men this was approximately so, but for women there was a recent
rise in recorded incidence not seen in the mortality data. This
divergence raises the possibility that the rise in women is an arte-
fact of improved registration, and examination of mortality/
incidence ratios over time suggest that this may well be so: at ages
70-84 years, for instance, this ratio decreased from 138.5% in
1960-64 to 96.2% at the end of the 1980s, while 5-year survival
remained under 5% (Black et al, 1993). In men there was also a
decrease in the mortality/incidence ratio, but starting from a lower
initial figure, which may indicate less initial under-registration.
The main known risk factor for cancer of the pancreas is
smoking, but with a much lower relative risk than that for lung
cancer. The slight peak ofpancreatic cancer in men born in 1900-04
corresponds to the much larger peak of lung cancer in men in the
same cohort, suggesting that smoking trends may have had an effect
on the pancreatic cancer rates. In women, the peak cohort for lung
cancer was that born in 1920-24, and for pancreatic cancer there
was a peak for those born in 1925-29. The pancreas is a deep
abdominal organ and diagnosis ofpancreatic malignancy is not easy,
so the trends, particularly at older ages, may have been affected by
changes in completeness of diagnosis.
Cancer of the larynx (Figure 9)
Mortality from cancer of the larynx in men showed a pattern remi-
niscent of that for oral and pharyngeal cancers. There was a large
increase for men aged 35-49 years since 1970-74 (although not as
large in proportional terms as that for oral and pharyngeal
cancers), and at older ages a modest decline. In women aged
35-49 years rates declined to about a third of their original level,
and at older ages there was no clear trend. Incidence trends, unex-
pectedly, were very different from this. In men there was an
increase of about two-thirds at each age since 1960, whereas in
women there was an increase of a half at ages 35-49 years, and a
tripling of rates at ages 50 years and above.
In cohort mortality data (not shown), there were peaks in risk
for men born in 1875-79 and those born in 1940-44, whereas in
women there were peaks for those born before 1885 and those
born in 1915-19. In cohort data for incidence (not shown) there
was again a peak for men born in the 1940s, but for women there
were peaks for those born in 1925-29 and perhaps 1940-44.
The increase in laryngeal cancer mortality in young men in
recent years accords with the increases for oropharyngeal cancers
and oesophageal cancers in this group, and seems likely to reflect
smoking and drinking, as 80-90% of laryngeal cancers in Western
countries can be attributed to these habits (Tomatis et al, 1990). As
noted previously (see p. 4), the prevalence of smoking has
decreased in young men in Scotland in recent years, and probably
average smoking has decreased for several decades, so that the rise
in laryngeal cancer is likely to reflect increased drinking, and/or an
increased prevalence of individuals who both smoke and drink
heavily, as the effect of alcohol plus smoking is approximately
multiplicative.
The reason for the large divergence between incidence and
mortality rates over time is not clear. Although it might in part
reflect improved survival, the scale of difference is too large to be
explained by the changes in treatment that have occurred, or by the
changes in survival for the period for which data are available:
between cases incident in 1968-72 and those incident in 1983-87,
all-age 5-year survival increased from 48.6% to 53.0% (Black et al,
1993). It is possible that registration has improved greatly or that the
diagnostic or coding boundaries for laryngeal cancers in incidence
and mortality data have diverged overtime; there is potential forthis
in the problematic discrimination between the larynx and adjacent
sites coded to the oropharynx and hypopharynx (Muir, 1992).
Cancer of the lung (Figures 10 and 11)
Mortality from lung cancer in men has declined at ages under 70
years since 1965-69, and at age 70-84 years since 1980-84. The
greatest proportional decrease has been at the youngest ages: at
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Table 2 Cutaneous malignant melanoma incidence ratesa at ages 15-84 by anatomical site, Scotland, 1960-4 to 1985-90
1985-90 1985-90
Site Males rate as % Females rate as %
of 1960-4 of 1960-4
rate rate
1960-4 1985-90 1960-4 1985-90
Head and neck 0.9 2.2 243 0.7 2.0 274
Upper limb 0.3 1.5 600 0.3 2.2 721
Trunk 0.4 3.3 765 0.4 1.5 391
Lower limb 0.5 1.8 373 1.2 6.6 568
Other and unspecified 0.2 0.2 140 0.3 0.3 85
Total, all sites 2.2 9.1 405 2.9 12.7 434
aRates per 100 000 population, age-standardized to the Scottish population of 1971.
age 15-34 years, rates are now less than a fifth of those in
1960-64. In women too there has been a decrease at the youngest
ages (15-34 years), to about a third of the 1960-64 rate; at age
35-49 years changes have been small, but at older ages there have
been large increases. As a result ofthe difference in trend between
the sexes, the all-age mortality rate in women is now 41% of that
in men, whereas 30 years ago it was only 13% ofthe contemporary
male rate. For incidence (not shown), a similarpattern was present.
When analysed by cohort, there was a clearpeak in mortality for
men born in 1900-04 and women born in 1920-24 and then in
each sex a decline that continued until at least the 1955-59 bfrth
cohort. Incidence data were similar (not shown).
Longer term secular data for lung and pleural cancers combined
(see Materials and methods) (Figure 11), which are effectively the
trends forlung cancer aspleural canceris comparatively uncommon,
show low rates in each sex until the mid-1920s, and then in men a
steep increase for 50 years to a peak in 1970-74, and in women a
lesser increase, mainly since 1960, that has yet to reach its peak.
The rates oflung cancer in men in Scotland from the late 1950s
to the 1970s were the highest national rates recorded in the world,
and in women from the early 1950s to the early 1980s were the
second highest, based on countries included in the compendium by
Kurihara et al (1989). These rates reflect the high level ofsmoking
in Scots born earlier in the century, and the trends are largely the
result ofchanges in smoking habits (see p. 5) and in the tar yield of
cigarettes, which has been decreasing in the UK since the Second
World War (Wald et al, 1988). The recent decreases in rates are
also, to a lesser extent, a reflection ofdecreases in air pollution in
urban areas (Doll, 1990) and improvements in industrial hygiene.
Domestic exposure to radon in air probably causes a few per cent
of lung cancers, and as radon concentrations are increased by
double glazing and other draught proofing, one may speculate that
average radon concentrations in houses might have increased over
time and provided a small counterweight to the decreases in
smoking and the other risk factors described above. At older ages,
at least, new diagnostic technologies - fibreoptic bronchoscopy,
fine-needle biopsy, and computerized tomography - may have had
some effect on rates. The overall effect, however, could have been
either to increase or decrease rates: the new methods could have
increased the number of lung cancers diagnosed, but also may
have reduced the number ofinstances in which other lung patholo-
gies were misdiagnosed as primary lung cancer (Gilliland and
Samet, 1994).
Cancer of the pleura (Figure 12)
Recorded mortality from cancer of the pleura has increased by
more than 12 times in men and more than five times in women
since 1958-59. There have been large increases in incidence too,
especially in men aged 70-84 years (over 100 times).
In cohort mortality data the increase in men continued consis-
tently up to the cohort born in 1940-44, whereas in women, based
on small numbers, there was no increase beyond the cohort born in
1925-29. Incidence data by birth cohort (not shown) displayed a
similar pattern.
Cancer of the pleura in Scotland is mainly the result of occupa-
tional exposure to asbestos, and the cancer trends reflect past
trends in this exposure as well as, probably, improvements in
completeness ofdiagnosis. The numbers of cases in the population
can be expected to rise for about 20 years to come (Peto et al,
1995).
Malignant melanoma of the skin (Figure 13)
Cutaneous melanoma mortality has more than doubled in each sex
since 1953-54. In women the greatest increases have been at
younger ages, whereas in men increases have been similar at each
age-group. Incidence data show much greater increases than for
mortality - over fourfold in each sex over the shorter period for
which data are available.
There have been considerable differences in the rate ofincrease
in melanoma incidence by anatomical site (Table 2): six- or seven-
fold increases have occurred since 1960-64 for upper limb
melanoma in each sex, trunk melanoma in men, and lower limb
melanoma in women, whereas much smaller increases have
occurred for other site-sex combinations.
In cohort data, the increase in all-site melanoma mortality in
men took place in generations born up to 1930-34, and the
increase in women in those born up to 1920-24, but subsequently
there was no clear trend. In incidence data, there were large
increases in women through to the most recent cohorts, whereas in
men the increase was slight for those born after 1930-34.
The increasing incidence of melanoma in Scotland parallels
similar increases in white populations worldwide, which have been
occurring as far back as data have been available. Completeness
and accuracy ofmelanoma registration data in Scotland is probably
particularly high because the routine cancer registration system is
British Journal ofCancer (1998) 77(Supplement 3), 1-16 0 Cancer Research Campaign 19988 AJ Swerdlow et al
supplemented by data from the Scottish Melanoma Group, an
independent pathologist-based registration system (MacKie et al,
1992). The registered melanoma incidence rates in Scotland are
appreciably above those for England and Wales, despite the higher
latitude ofScotland; the difference is probably in part real, although
better registration may also have contributed to it.
The mortality trends in Scotland are similar to those in other
white populations, in which the rate of increase has been lower for
mortality than incidence, and on a cohort basis rates have stabilized
or started to decline in recent birth cohorts (NRPB, 1995).
Epidemiological investigations around the world suggest that the
increases in melanoma rates are largely real and are likely to be due
primarily to changes in UV exposure behaviour, and particularly to
increasing recreational sun exposure of untanned skin (NRPB,
1995). For the Scottish population, this is likely to be a mixture of
more sunbathing and outdoor recreation while in Scotland, and
more overseas holidays. There may also have been some effect
from the rising use of artificial tanning lamps and beds.
The greater increase in incidence than mortality rates from
melanoma is in part due to improved treatment and probably to
earlier presentation, at a stage when treatment is more successful.
It may also reflect an increasing tendency to biopsy borderline
malignant lesions. Over the past 15 years, at least, the proportion
ofmelanomas that are <1.5 mm thick at presentation has increased
considerably (MacKie and Hole, 1996). All-age 5-year survival
from melanoma in Scotland improved from 55.4% for cases inci-
dent in 1968-72 to 69.7% for those incident in 1983-87, and the
improvement was particularly marked at the oldest ages - from
24.1% to 45.4% at age 75-84 years (Black et al, 1993). The diver-
gence of incidence and mortality trends is probably not, however,
due to changed pathological criteria for borderline malignant
lesions: an international collaborative study of melanoma
pathology, which included two centres in the UK, although none
specifically in Scotland, concluded that changes in histological
criteria for malignancy could not account for more than a small
amount of the rising rates (van der Esch et al, 1991).
Breast cancer in women (Figure 14)
Percentage changes in breast cancer mortality over the last 80
years have been small compared with those for most other cancers,
but because breast cancer is so common the changes are of impor-
tance. At ages under 45, mortality increased to a peak in 1935-39,
rose to another peak in 1975-84, and has since fallen. (Ages under
45 years are taken here to represent premenopausal ages. Ideally
this analysis would divide the age groups at 50 not 45 years ofage,
but this is not possible with the age-categorization of data avail-
able from early in the century.) At age 45-84 years there was also
a rise to a peak in 1935-39, and to another in 1985-89, and then a
lower rate in 1990-93.
Examining trends since 1953 in more detail, there were
increases of 20% at age 50-69 years and 10% at age 70-84 years,
with a slight downturn at each age group in 1990-93, and at ages
35-49 years, a rise of about 30% and then a decrease.
The increases at post-menopausal ages have been larger for
incidence than mortality. At age 35-49 years there was an increase
in incidence up to 1980-84, followed by a small decrease, and at
15-34 years, a marked increase up to 1970-74, but then a decline.
In cohort mortality and incidence data a peak was reached for
women born in 1930-34, with a decline since. Cohort data for
incidence by single year of birth did not show any change in risk
for those born or reaching the age ofpuberty during the depression
of the early 1930s or the years of the Second World War.
Breast cancer is the most common cancer in women in Scotland,
and the Scottish mortality rates are among the highest in the world
(Kurihara et al, 1989). The increase in breast cancer mortality at
older ages over the last 40 years is an important part of the increase
in cancer mortality overall in older women, and is unlikely to be
artefactual. This is not a site where the mortality data are likely to
have been affected appreciably by changes in diagnostic technology
or criteria. Breast cancer mortality data at older ages are particularly
susceptible to artefacts of death certification and of coding selection
of underlying cause of death (Grulich et al, 1995), but again this
does not appear likely to explain most of the increase. Screening in
recent years may have resulted in the detection of incident cases that
would not otherwise have been known, or that would have been
diagnosed later, but it is unlikely to have increased apparent
mortality, and indeed in the long term should lead to a decrease in
mortality. The reason for the increase in breast cancer for cohorts
born up to the early 1930s is uncertain. Earlier age at menarche and
increased height (or correlates of these), perhaps because of better
nutrition in childhood, may in part be responsible, as may changes in
childbearing patterns and in post-menopausal obesity. The effect of
the increasing use of post-menopausal hormone replacement
therapy is likely to have been slight (Ursin et al, 1994). There is
evidence, mainly from international ecological correlations, that
high fat consumption may be a risk factor for breast cancer; in the
period for which national Scottish data are available, fat consump-
tion increased from 95 g per head per day in 1953 (MAFF, 1955) to
114 g in 1969 (MAFF, 1971), and then decreased to 89 g in 1990
(MAFF, 1991). For the period before these National Food Survey
data, aggregation of data from ad hoc studies suggests that the
percentage of energy in the Scottish diet derived from fat increased
considerably from the 1920s (25.0%) to the 1930s (34.9%), slightly
decreased in the 1940s (33.5%), but then increased in the 1950s
(38.6%) (Stephen and Sieber, 1994). These early dietary trends
show a considerable parallel with the breast cancer trends, espe-
cially the interruption of the upward trend during the period of
rationing during and after the Second World War.
Termination of pregnancy (therapeutic abortion) is another
potential risk factor for breast cancer. Abortion became legal in
Scotland in April 1968, since when abortion rates have risen from
3.5 per 1000 women aged 15-44 in 1969 (ISD, 1977), to 7.3 in
1980 (ISD, 1982), and 9.8 in 1990 (ISD, 1991).
The decrease in incidence ofbreast cancer in the most recent birth
cohorts in Scotland corresponds with a decrease seen also in
England and Wales (dos Santos Silva and Swerdlow, 1995). Data on
age at first birth in the Scottish population are available only since
1976, and show an increase from an average of23.1 years in 1976 to
25.7 years in 1995 (ISD, 1997) - a pattern that might be expected to
contribute to an increase, not a decrease, in breast cancer incidence.
The mean fertility by age 45 years of women in Scotland increased
from 2.51 liveborn children per woman for women born in 1931 to
2.63 for those born in 1934, but then decreased steadily to 2.03 for
women born in 1951 (RG for Scotland, 1996); more recent cohorts
have not yet reached age 45 years, but up to the age they have
currently attained their fertility rates have continued to decline. Like
the age at first birth trends, the fertility trends are those that would
accord with a rising, not falling, incidence ofbreast cancer.
The decrease in breast cancer incidence has coincided with the
introduction and widespread use of oral contraceptives, which
would not accord with an aetiological effect oforal contraceptives.
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It is not due to the national screening programme, which was only
for women aged 50 years and above. The quality of breast cancer
registration data appears to have been high throughout: the
percentage of cases under age 65 years histologically verified has
increased from 90% in 1960-64 to 95% in 1985-89, and the
percentage at these ages registered solely from death certificates
has remained under 2%. The recent downturn in breast cancer
mortality at younger ages is due partly to the downturn in inci-
dence, but at older ages incidence has not decreased. At least in
part the decrease in mortality is the result of better treatment by
tamoxifen and other new effective treatments (Stewart, 1992;
Early Breast Cancer Trialists' CollaborativeGroup, 1992). All-age
5-year survival from breast cancer in Scotland increased from
49.5% for cases incident in 1968-72 to 56.3% for those incident in
1983-87, with similar rates of improvement at each age-group
(Black et al, 1993). The national breast cancer screening
programme in Scotland was introduced too recently to account
fully for the decrease in mortality, and for incidence it might well
initially have given an artefactual increase (Ursin et al, 1994). The
programme in Scotland attempts to screen by mammography all
women aged 50-64 years every 3 years, and to screen women
older than this 3 yearly on demand. The first centres opened in
1988, and national coverage was obtained in 1991 (ISD, 1993); in
1991-92, the first year for which reliable data are available, 91 028
women were screened, and 437 invasive malignancies detected
(ISD, 1993), compared with around 2000 breast cancers per year
registered in women aged 50-84 years in the late 1980s.
Cancer of the cervix uteri (Figure 15)
Trends in mortality from cervical cancer before 1970 were uneven,
but since then there has been a clear decrease, except that at ages
under 35 years rates have been erratic, based on small numbers.
Incidence data show a similar pattern for ages over 35 years, but at
ages under 35 years there has been a dramatic increase since 1960,
with the rate more than tripling.
Cohorts born in 1910-24 had high mortality, there was then a
steep decrease to a minimum for the cohort born in 1930-34, and
an increase to the 1955-59 birth cohort, the most recent for which
there was a substantial number ofdeaths. Incidence data by cohort
were similar, but in addition displayed a clear decrease in the
cohorts born in the 1960s.
Cervical cancer trends are potentially open to artefact if the
proportion of uterine malignancies whose exact site is not speci-
fied is high, especially if this proportion changes. For incidence,
the proportion was low (5.8%) and did not change substantially
over time; for mortality, the proportion has been greater (19.6%),
and has decreased from 43.2% in 1953-54 to 9.4% in 1990-93. At
all ages combined, judging from English and Welsh experience
(Swerdlow, 1989), most of the unspecified tumours are likely to
have been ofthe corpus uteri, not the cervix, so that although there
was probably an increase in recorded mortality due to greater
precision of death certificate diagnoses, this effect is unlikely to
have been large. At young ages, however, the great majority of
uterine cancers are cervical, so that there is a greater chance that
uterine cancers not further specified were in fact cervical: for
instance at ages 15-34 years in 1990-93, 97% of uterine cancer
deaths were stated to be cervical, and at ages 35-49 years, 91%
were stated as cervical, so at these ages uterine deaths not further
specified may well have included a substantial proportion of
cervical cancers. The unspecified deaths diminished from 17% to
3% of all uterine cancer deaths at age 15-34 years, and 31% to 4%
at age 35-49 years, from 1953-54 to 1990-93, and this may well
have had an appreciable upward effect on the cervical cancer
mortality trends.
For incidence, however, the effect will have been slight as few
uterine cancers at young ages were of unspecified subsite - under
1% at age 15-34 years, and under 2.5% at age 35-49 years. The
quality of cervical cancer registration data also appears to have
been high: well over 95% of cases in 1960-89 at ages under 65
years and around 85% of cases at ages 65-84 years had histo-
logical verification, and under 1% ofcases under age 65 years and
around 2-3% of cases at ages 65-84 years were registered from a
death certificate only.
Cervical cancer rates may also be artefactually influenced by
diagnostic and coding boundaries between cervical malignancy
and cervical intraepithelial neoplasia (cancer in situ and
dysplasia), especially as screening will reveal many cases of less
severe disease. We have no data on whether these boundaries have
altered, but it seems unlikely that this could explain the great
variation in trend by age in recent years.
The decreases in cervical cancer at older ages in Scotland
accord with decreases in many Western countries, probably mainly
because of changes in sexual behaviour, although there may have
been some effect also of declining parity (on which data are not
available for cohorts born before 1931 - see p. 8) and possibly of
better genital hygiene. Rates in recent years are likely also to have
been reduced by screening. The cervical screening programme
started in certain parts ofScotland in the early 1960s (Duguid et al,
1985; MacGregor et al, 1985), but was uneven in coverage until a
computerized call-recall system was introduced in the late 1980s.
The smear rate, per 1000 women aged 15 and above, increased
from 74 in 1967 (ISD, 1982) to 133 in 1980 (ISD, 1982) and 261 in
1990 (ISD, 1991). Rates may also have been diminished by a
rising frequency of hysterectomy: the age-standardized hysterec-
tomy rate (European Standard Population) increased from 150.7
per 100 000 per year in 1961-65 to 241.2 in 1976-80 and 288.5 in
1991-95 (ISD, unpublished), which will have reduced the
numbers of uteruses at risk of cancer. Smoking has been found
associated with cervical cancer risk, although whether causally is
uncertain; cervical cancer trends resembled those for lung cancer,
as a marker of smoking, in that there was a peak of incidence in
women born around 1920, but the rise in recent cohorts for
cervical cancer was not present for cancer ofthe lung.
The increase in cervical cancer incidence in Scottish women
born from the Second World War onwards, who reached sexual
maturity during the period when oral contraceptive use became
widespread, has been seen also elsewhere in the British Isles, and
in Australia, New Zealand and eastern Europe (Beral et al, 1994).
Its presence in mortality as well as incidence data suggests that it is
not due to changes in diagnostic criteria for borderline malignant
lesions or to case finding from screening. The increase is likely to
be due to changed sexual behaviour. Supporting this is the fact that
it occurred at the time ofa large upsurge in venereal disease - there
were 1768 new cases in women presenting to clinics in Scotland in
1950, and 1888 in 1960, but this increased to 4251 in 1970 and
7314 in 1973 (ISD, 1977). An element of the increase might also
have been a direct effect of oral contraceptives on risk, although it
is uncertain whether this association is causal.
The steep decrease in cervical cancer incidence in cohorts born
in the 1960s, based on moderate numbers of cases, has not to our
knowledge been reported for other countries. It might indicate the
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effect of screening (although this is intended to be primarily for
older women) and/or an effect of AIDS on sexual behaviour
(including barrier contraceptive use). Recent data on sexually
transmitted disease clinic attendances give some support to the
latter interpretation. Peak attendance rates in women under age 35
years were reached in 1985-87 (ISD, 1989), and then decreased by
13-16% (depending on age) by 1990 (ISD, 1991).
Cancer of the ovary (Figure 16)
Ovarian cancer mortality has increased at older ages over the past
40 years, but at younger ages there was little change up to the
1970s, and then a marked decline, especially at ages under 35
years. The increase at older ages was present, and indeed slightly
more marked, in incidence data. At young ages there were slight
increases in incidence.
In cohort data an increase in mortality was seen in generations
of women born up to 1915-19, with a decline thereafter. In inci-
dence data (not shown), there was an increase from cohorts born
late in the last century until the 1925-29 cohort, but subsequently
no clear trend.
The decrease in mortality from ovarian cancer at younger ages
while incidence has not diminished, reflects the introduction of
effective chemotherapy in the 1970s: at age 35-44 years, 5-year
survival improved from 35.1% for cases incident in 1968-72 to
56.2% for those incident in 1983-87, and there were lesser
improvements at age 45-54 years and 55-64 years (Black et al,
1993). The lack of a similar divergence between incidence and
mortality trends at older ages, however, implies that the effect of
chemotherapy has been small, on a population basis, at these ages.
Again this accords with the available survival data: from cases inci-
dent in 1968-72 to those incident in 1983-87, there was no material
improvement in survival at age 65-84 years (Black et al, 1993).
Trends in ovarian cancer incidence (other than to the extent they
are artefacts ofdiagnosis or registration) are likely to reflect mainly
changes in parity, age at menarche and in recent cohorts, oral
contraceptive use. Parity has been decreasing, at least for cohorts
born since the mid-1930s (see p. 8). The rates will also have been
somewhat affected by hysterectomy and oophorectomy rates as
these affect the number of ovaries at risk. The rate of hysterectomy,
which often includes removal of the ovaries, has increased greatly
since 1961-65 (see p. 9), and the rate of oophorectomy without
hysterectomy increased from 62.6 per 100 000 (standardized to the
European Standard Population) in 1961-65 to 90.5 in 1981-85, and
then decreased to 72.3 in 1991-95.
In England and Wales and in Sweden, decreases in ovarian
cancer incidence have been seen in recent cohorts, probably conse-
quent on increased use of oral contraceptives (Adami et al, 1990;
Dos Santos Silva and Swerdlow, 1995). There is no clear evidence
that this has yet occurred in Scotland.
Cancer of the prostate (Figure 17)
Mortality from cancer of the prostate at age 50 years and above
changed little until the early 1980s, but has since increased appre-
ciably. At younger ages, deaths from this malignancy are rare and
rates have been erratic. Incidence rates have risen more steeply
than mortality.
Changes in mortality from prostatic cancer in cohort data (not
shown) have been slight, except for an apparent increase, based on
small numbers, in the most recent birth cohorts. In incidence data
by cohort (not shown), rates rose for the cohorts born up to
1925-29, and were erratic thereafter.
The large secular increase in recorded incidence of prostatic
cancer has been seen in many countries and is likely mainly to
reflect increased detection through the increasing use of
transurethral resection (TURP) to treat benign prostatic hypertrophy
(Potosky et al, 1990). This increased detection during life might also
have had some effect on recorded mortality rates. The proportion of
registered cases for which histological verification was available
increased greatly, from 55% in 1960-64 to 91% in 1985-89 at age
35-64 years, and from 51% to 83% at age 65-84 years. The intro-
duction ofprostate-specific antigen screening in the last few years of
the study period may also have had some effect. Autopsy can reveal
'latent' prostatic malignancies that would not otherwise be detected.
For the period for which data are available, however, autopsy rates
have decreased slightly - from 16.2% ofdeaths in 1965, to 15.9% in
1980 and 14.5% in 1994. It may also be the case that changes in
certification practice account for part of the rise in recorded under-
lying cause mortality from this cancer, as appears to have occurred
in England and Wales (Grulich et al, 1995). Nevertheless, it seems
likely that mortality rates will have been less affected than incidence
rates by artefacts of incidental diagnosis of latent tumours, and
changes in certification seem unlikely to explain the scale of the
mortality rise, so it may well be that the increase is at least in part
real, although too little is known about prostatic cancer aetiology to
assess the factors that might be responsible.
The divergence between incidence and mortality trends is what
would be expected if TURP has led to greater incidental diagnosis
of relatively good prognosis tumours. Surprisingly, however, it does
not accord with survival data, which one might then expect to show
apparent improvements, as more-benign tumours were added to the
'incident' cases. The published survival data show little change: all-
age 5-year survival was 27.8% for cases incident in 1968-72 and
30.5% for those incident in 1983-87 (Black et al, 1993).
Cancer of the testis (Figure 18)
Data on mortality from cancer of the testis in Scotland are avail-
able back to 1931. At age 50 years and above, rates were erratic
until the 1950s but have since decreased by a half. At ages under
50 years, rates more than tripled from 1931-35 to 1976-80 but
subsequently decreased steeply, by about two-thirds. Analyses for
finer age groups than in Figure 18 showed similar patterns.
Incidence rates of cancer of the testis since 1960 have changed
little at older ages, but more than doubled at ages under 50 years.
In cohort mortality data (not shown), there have been generally
downward trends for men aged 50 years and above, whereas at
ages under 50 years a peak was reached for the cohort born in
1935-39, with a large decline subsequently. Cohort trends in inci-
dence for men aged 50 years and above (not shown) were uneven,
based on small numbers; for men under 50 years there was an
increase up to the cohort born in 1960-64, but no further rise for
those born subsequently. Cohort data by single year of birth (not
shown) gave no indication of an altered risk for men born during
the Second World War or the depression ofthe 1930s.
Increasing incidence of testicular cancer at younger ages has
been seen in white populations around the world for as long as
reliable data have been available (Swerdlow, 1997). There is no
reason to believe that diagnostic factors could have had a
material effect, or that registration improvements could account
for more than a minority of the increase, at most. The reason for
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the rising rate is not known. Cryptorchidism accounts for too small
a proportion of testicular cancers for changes in its frequency to
explain the increase in testicular cancer. Increasing in utero expo-
sure to environmental oestrogens, affecting development of the
testis (Sharpe and Skakkebaek, 1993), or decreasing age at puberty
and increasing sedentariness and lack of exercise (Forman et al,
1994), have been recently hypothesized as causes, but there is
insufficient knowledge about their aetiological roles or data on
their trends to assess if they can account for the rising risk. There
was no sign in the Scottish data ofthe halt in the rising cohort trend
for men born during and soon before the Second World War that
has been observed in Denmark, Norway and Sweden (Bergstrom
et al, 1996), but the effect of the War on nutrition was probably
less severe in Scotland (which was not occupied) than in occupied
Denmark and Norway, at least.
The decreasing mortality from testicular cancer at older ages
over many decades, and the decrease in mortality at young ages
since the 1970s, are trends that have been found elsewhere. The
decrease in mortality in recent years relates to improved survival
from the introduction ofeffective chemotherapy. Comparing cases
incident in 1968-72 with those incident in 1983-87, all-age
survival improved from 60.7% to 86.8% (Black et al, 1993), and
there were especially large improvements in young adults - from
42.6% to 89.5% at age 15-24 years, and from 65.0% to 91.5% at
age 25-34 years. There were probably also substantial improve-
ments in survival in the years before 1968 as a consequence of the
introduction of intensive radiotherapy for seminomas.
Cancer of the bladder (Figure 19)
We have included in the analyses ofbladder cancer, cancers of the
urethra and certain other non-renal urinary tumours, to improve
the degree to which the same group of cancers can be identified
('bridged') in different ICD revisions. The analytic category is
effectively bladder cancer, however, as these contribute over 98%
of cancers within the codes analysed.
Mortality from cancer of the bladder at ages under 70 years
showed no consistent trend (the apparent early decrease for
women aged 35-49 years is based on few deaths). At age 70-84
years, however, rates in men have almost doubled and in women
have increased by a half since 1953-54. Increases in incidence
have been seen at all ages older than 35 years, with the largest
increase at the oldest ages.
Mortality changed little between cohorts born late in the last
century and those born in 1930-34, but for subsequent cohorts
there was a small decline (not shown). In incidence data, there
were increases up to cohorts born in the 1920s, and a generally
downward trend for cohorts born subsequently.
The main known risk factor for bladder cancer is smoking, but in
men neither the incidence nor the mortality trends paralleled those
forlung cancer, for which cohort-based data showed a peak for men
born in 1900-04. The cohort data in women, for incidence at least,
showed a greater resemblance to the pattern for lung cancer, with a
peak in those born in 1920-24. Trends in occupational chemical
exposures and phenacetin use might affect bladder cancer trends
(Silverman et al, 1996) as might, to a lesser extent, trends in pelvic
radiotherapy and in chemotherapy, notably with cyclophos-
phamide, but there are no data on changes in these exposures over
time in Scotland, except that manufacture and use of certain
aromatic amines ceased at several large companies in Britain
several decades ago (Swerdlow, 1990).
The divergence between incidence and mortality trends for
bladder cancer accords with improvements in recorded survival:
from cases incident in 1968-72 to those incident in 1983-87, all-
age 5-year survival increased from 40.1% to 48.4% (Black et al,
1993). This improvement could indicate betterresults oftreatment,
or the inclusion of greater numbers of non-aggressive tumours in
the incidence data, which could artefactually have increased inci-
dence rates. This might have occurred ifclinicopathological termi-
nology or criteria for papillomas of the bladder (Saxen, 1982) or
registry interpretation or coding of invasiveness of bladder
tumours (Lynch et al, 1991) had changed over time; we have no
data on whether this occurred, and the data available to us were
solely for tumours coded as malignant.
Cancer of the eye (Figure 20)
At age 15 years and above, ocular cancers are largely melanomas,
and at younger ages ocular melanomas rarely occur, so ocular
cancer trends at 15 years and above give a good proxy for trends in
ocular melanoma (Hakulinen et al, 1978). Ocular cancer mortality
at age 15-84 years in men showed no clear trend. In women, there
was an increase from 1953-54 to 1970-74, and perhaps a subse-
quent decrease. Incidence data by contrast showed substantial
increases, especially in recent years, with rates in each sex in
1985-90, 60% greater than those in 1960-64. We have not shown
age-specific trends in ocular cancerbecause ofsmall numbers. The
mortality trends did not vary clearly by age, but incidence rates
tended to increase most steeply at the oldest ages.
The apparent rise in incidence of melanoma of the eye during
the 1980s may be an artefact as developments in the ophthalmic
oncology service in Scotland around this time attracted many
referrals of patients from outside Scotland, some of whom may
inadvertently have been registered as if Scottish residents.
Whereas the aetiology of cutaneous melanoma is known to be
related closely to UV exposure, the relation of ocular melanoma
risk to UV is far less certain (NRPB, 1995). It is notable in this
respect that ifthere has been an increase in eye cancer incidence in
Scotland over the past 30 years (and it is uncertain how much ofthe
apparent increase is due to the above artefact or improved registra-
tion), it has clearly been much less than the increases that have
occurred in cutaneous melanoma rates. By implication, the increase
in recreational and vacational intermittent sun exposures that is
believed to be the main cause ofthe rise in cutaneous melanoma has
had far less, ifany, effect on ocular melanoma incidence trends.
The difference between the incidence and mortality trends for
ocular cancer might have occurred because of artefact in the inci-
dence data (see above) or improved cancer registration, or there
may have been truly increasing incidence counterbalanced by
improved survival as a reason for the approximately unchanged
mortality. No survival data are available for cancers of the eye in
Scotland.
Ocular melanomas are sometimes stated on death certificates
simply as 'melanoma', and if the correct site is not ascertained they
will then be coded underthe ICD rules to acategory within cutaneous
melanoma, rather than to ocular malignancy. The large increase in
rates of cancer of unspecified site in Scotland over the last 40 years
suggests that specificity ofdeath certification has deteriorated, so that
specification of site for ocular melanomas may also have become
worse. The effect is likely to have been small (Swerdlow, 1989),
however, and is not likely to account for most ofthe observed diver-
gence between ocular melanoma incidence and mortality.
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Cancer of the nervous system (Figure 21)
Certified mortality from nervous system cancer increased several-
fold at age 70-84 years over the study period, especially in men,
but there were far smaller increases at age 50-69 years, and small
decreases in younger adults. In boys but not girls there has been a
decrease in recent years. The differences between age groups in
nervous system cancer trends have been so large as to change the
cross-sectional age distribution of mortality from this cancer in
Scotland - in the 1950s a peak was reached at age 50-69 years,
with a decrease at older ages, whereas now rates rise progressively
with increasing age in a manner similar to that for most cancers.
In incidence data too (not shown) there have been large secular
increases in nervous system cancer rates at older ages, although
less pronounced than those for mortality. There has also been a
moderate increase at younger adult ages for men but not women,
and increases for children of each sex. As a result of the larger
increases for mortality than incidence at age 70-84 years, recorded
mortality rates at these ages are now, surprisingly, appreciably
greater than recorded incidence.
In birth cohort data, a large increase in mortality was seen up to
cohorts born around 1915-19, with a slight decrease for those born
thereafter. The age distribution within cohorts has altered, from a
peak around age 65 years to a pattern of rising rates with
increasing age. In incidence data (not shown), there was also an
increase for cohorts born up to the early years ofthe century, but in
addition an increase for males born since 1960-64 and females
born since 1965-69.
The above analyses do not include benign and unspecified
tumours of the nervous system because incidence data on these
were not available and we wished to make the incidence and
mortality analyses comparable. It is desirable to consider benign
and unspecified as well as malignant tumours when examining
nervous system cancer trends, however, because they frequently
cannot be distinguished in patients in whom the diagnosis is made
without biopsy. When benign and unspecified tumours were
included in the mortality analyses, the trends were similar to those
shown, unsurprisingly as they constituted only 15% of deaths
(under age 85), but with a tendency for the percentage increase at
older ages to be greater when these tumours were added. Coding
of brain tumours as malignant in mortality data is considerably
dependent on the precision of information furnished by certifiers
(Swerdlow, 1989) (and the same is presumably true forregistration
data), so that the greater increase for all brain tumours than for
those specified as malignant might be a consequence of changed
certification practice.
The large apparent increases in incidence and mortality from
nervous system cancers at older ages in Scotland have been seen
also in many other countries (Ahlbom, 1990; Muir et al, 1994). They
have probably been caused, at least in part, by better diagnosis, for
instance through the introduction of computed tomography scans
and magnetic resonance imaging; judging from North American
data, however, these latter modalities may only account for a
minority of the increase (Desmeules et al, 1992). If biopsy rates
have decreased, then rising rates could be due to some extent to
more secondary malignancies in the brain being misclassified as
primary brain tumours -the proportion ofregistered nervous system
cancers that were histologically verified has decreased from just
over 80% in each sex in 1960-64 to 71% in males and 66% in
females in 1990-94. It is implausible that the large change between
cohorts in the age distribution ofmortality can have been other than
artefactual. Whether in addition to this artefactual increase there has
also been a real increase in incidence is uncertain.
The larger increases in recorded mortality than incidence rates
at older ages is paralleled to some extent by changes in published
survival from nervous system cancers, which at age 45 years and
above has deteriorated over the period (Black et al, 1993) (whereas
at younger ages there has been a considerable improvement). This
apparent deterioration in survival, and the lesser increase over time
for incidence than mortality, could have occurred if better diag-
nosis or registry data collection had reduced the number ofbenign
brain tumours or other brain lesions of good prognosis, catego-
rized as brain malignancies. Autopsy can uncover considerable
numbers of brain tumours at older ages undiagnosed during life
(Muir et al, 1994), and thus decreasing autopsy rates could reduce
the number of diagnosed non-fatal tumours; in the period for
which data are available, there was a slight decrease in the autopsy
rate (see p. 10).
Hodgkin's disease (Figure 22)
Mortality from Hodgkin's disease increased until 1970 and subse-
quently declined by at least a half at each age group in each sex,
except that for men aged 70-84 years the decline was less
pronounced. Incidence rates at age 50 years and above have
decreased by less than the decrease in mortality or (in men aged
70-84 years) not changed appreciably. At younger ages, incidence
trends have been inconsistent.
In cohort mortality data (not shown) there were decreases since
the cohorts born in 1885-89, but in incidence rates by cohort (not
shown) there was little change.
The decrease in mortality from Hodgkin's disease since 1970,
while incidence has decreased less or not at all, depending on age,
is the result of the great improvement in prognosis brought about
by intensive chemotherapy and radiotherapy. Judging from
published time trends in survival, however, this only provides an
explanation for the differing incidence and mortality trends at
younger ages: at ages under 65 years there were considerable
improvements in survival for cases incident in 1983-87 compared
with those incident in 1968-72 (Black et al, 1993), whereas at age
65 years and above survival barely changed.
The decrease in incidence rates at older ages may in part reflect
changed pathological classification of certain histological
subtypes of Hodgkin's disease as non-Hodgkin's lymphoma
(Banks, 1992). Recorded rates would also be affected if the speci-
ficity of reporting (or of registry data extraction) of histology of
lymphomas has altered over time as lymphomas not further speci-
fied are categorized in the ICD under the rubric for non-Hodgkin's
lymphoma, not Hodgkin's disease. The decreasing incidence and
mortality at older ages could also to some extent reflect decreasing
autopsy rates (see p. 10) as there is evidence that an appreciable
proportion of cases of Hodgkin's disease at older, but not
younger, ages are diagnosed only at post-mortem (Hasle and
Mellemgaard, 1993).
Non-Hodgkin's lymphoma (NHL) (Figure 23)
Mortality from NHL at ages 50 years and above has more than
doubled since 1953-54. At younger ages, in contrast, there have
been slight or no increases. Incidence has increased at all ages, and
the upward trend has been steeper than that for mortality, except at
age 70-84 years in women.
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In incidence data by birth cohort (and mortality data, not
shown), rates in each sex increased steeply up to the cohort born in
1915-19, changed little until the birth cohorts of the 1950s, and
then decreased.
The increase in NHL rates in Scotland accords with an
increasing trend in many other countries around the world (Devesa
et al, 1992), the aetiology ofwhich remains largely unexplained. A
small element arises from lymphomas due to immunosuppression
for transplantation and in recent years from AIDS-associated
lymphomas. These are relatively rare causes, however, especially
at older ages. A small proportion of cases are of other known
causation - adult T-cell leukaemias-lymphomas due to human T-
lymphotropic virus type 1 (HTLV-1) (which might have been
coded to leukaemia or NHL in Scotland during the period), and
lymphomas in persons with genetic immunodeficiency or
immune-related diseases such as coeliac disease; these causes are
also uncommon, however, and cannot account for the large rise in
rates. Other factors have been suggested as possible causes of the
increase - exposure to pesticides and phenoxyherbicides, and to
ultraviolet radiation or other factors that might alter immune status
- but it is not yet clear whether they are aetiological.
Certain artefacts might explain some of the increase, but again
not most of it. There may have been a transfer to NHL in recent
years of some lymphomas that previously would have been cate-
gorized as Hodgkin's disease (Banks, 1992). Small changes in
lymphoma rates could also have arisen from changes in classifica-
tion between NHL and certain leukaemias, and there has been
recategorization as malignant of certain (relatively uncommon)
lymphoid lesions that were previously considered benign (Banks,
1992). Better specification or coding of lymphomas of sites other
than lymph nodes (e.g. of the stomach or testis) might also have
had a minor effect. Under ICD rules such tumours should have
been coded to 'lymphoma' if the histology was stated, but if the
histology was not specified on the death certificate or cancer regis-
tration, or the ICD rules were not followed correctly, then they
could have been coded to the site at which they occurred. Judging
from the results of a pathology review of cases in part of England
over a 20-year period (Barnes et al, 1986), however, neither
changes in pathological criteria nor changes in completeness of
registration or coding can explain the increased rates.
It is possible that some of the increase might have occurred
through improved diagnosis ofcancers that were previously misdi-
agnosed as primaries of other sites or were categorized as malig-
nancies of poorly defined or unknown site, or that remained
undiagnosed. However, the sharply increasing rates of cancers of
unknown primary site, one ofthe most obvious sources oftumours
that might prove to be NHL with more precise diagnosis, are
scarcely supportive ofthis. On the other hand, the increase in rates
at older but not younger ages, for mortality in each sex and less
convincingly for incidence in men, is a pattern that might reflect
improved diagnosis (or a cohort effect from an aetiological agent
acting less in recent years).
Given the lack of plausible artefactual explanations for the
increase in NHL and the large scale ofthe increase, it seems likely
that at least part ofit has been real, due to as yet uncertain causes.
The divergence between trends in incidence and mortality from
NHL, especially at younger ages, reflects primarily the impact
of the introduction of effective chemotherapy and radiotherapy,
which can generally be used more aggressively and successfully at
younger ages. Five-year survival at age 35-44 years improved
from 38.9% for cases incident in 1968-72 to 60.5% for those inci-
dent in 1983-87, and there were similar increases at other ages
under 45 years, whereas at age 75-84 years the improvement was
from 9.3% to 15.1% (Black et al, 1993). Some of the divergence
between incidence and mortality trends might also be attributable
to improved completeness of cancer registration.
Multiple myeloma (Figure 24)
Myeloma mortality has increased sixfold in men and fourfold in
women at age 70-84 years since the early 1950s, and has increased
twofold or less at age 50-69 years. Few myeloma deaths occurred
at younger ages than this. Trends in incidence (not shown) at age
70-84 years have been similar to those for mortality, but at age
50-69 years there has been a greater increase than that seen for
mortality, and at 35-49 years there has also been an increase.
In cohort mortality data, there were large increases until those
born early in this century, and less marked decreases subsequently.
The shape of the age curve did not change appreciably between
cohorts. In incidence data (not shown) there was a similar pattern
to that for mortality, except that the decrease since the peak cohorts
was less pronounced in men and not present in women.
The increases in myeloma rates in Scotland, greatest at older
ages, are similar to those seen in many developed countries
(Cuzick, 1994), and have no known aetiological explanation.
Definitive diagnosis of myeloma requires relatively sophisticated
tests. Increases internationally have been greatest where rates were
initially low, and at ages (the elderly) when there was scope for
better ascertainment (Cuzick, 1994), and rates have increased
modestly or not at all in places where there was originally espe-
cially good ascertainment (Linos et al, 1981; Turesson et al, 1984).
It therefore seems likely that although there might be an element of
real increase, much or all of the rise in rates internationally may be
an artefact of improved diagnosis. There appears to be no reason
why the same interpretation should not apply to the Scottish
results.
The differences in trend between incidence and mortality data
may well be artefactual: recorded survival from myeloma has
scarcely changed over the period (5-year all-age survival was
13.2% for cases incident in 1968-72 and 15.4% for those incident
in 1983-87 (Black et al, 1993)).
The cohort analyses imply that if there is a real element to the
rise in recorded myeloma rates, the aetiological factors concerned
have long ceased to increase - the upward trend in myeloma
stopped or even reversed for cohorts born after the early part of
this century.
Leukaemia (Figures 25 and 26)
Leukaemia mortality has increased at age 70-84 years except in
recent years, at age 50-69 years in men and 35-69 years in women
it has remained almost unchanged, and at younger ages it has
decreased considerably. In incidence data there were again large
increases at older ages, but also moderate increases at most
younger ages.
In cohort mortality data (not shown) there were two peaks in each
sex, the firstforcohortsborn attheturn ofthecentury, andthe second
for those born in the 1950s. In incidence data by birth cohort there
were less convincing peaks for cohorts born early in this century and
in 1945-49, but, in addition, especially in men, there was an increase
in cohorts born since 1970. Because this latter increase was
composed of young age groups (necessarily, since based on recent
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years ofbirth) we reanalysed cohort incidence data only for age 0-24
years (not shown); in these analyses, increases occurred for males
born since 1965-69 and females born since 1960-64.
Examining the secular data by histological type of leukaemia and
single year of age (Figure 26), the increase in leukaemia at young
ages occurred mainly for lymphoid leukaemia, and although it was
present throughout childhood, it was most evident numerically at the
peak incidence in young children around age 3-4 years.
The increase in leukaemia incidence and mortality at age 70-84
years in the early part of the study period, but ceasing more
recently, is a pattern seen in several other Western countries
(Kinlen, 1994). It may in part or entirely be a result of improved
diagnosis and registration, although a real increase in incidence
cannot be discounted. The known causes of leukaemia in adults -
ionizing radiation, alkylating chemotherapy, benzene and probably
chloramphenicol - account for relatively few cases, and could not
explain the increase. Cigarette smoking may be a cause of
leukaemia, but the leukaemia trends did not resemble those for
lung cancer as a proxy for smoking. The large decline in mortality
at younger ages is the consequence of improved treatment by
chemotherapy and bone marrow transplantation. Although
leukaemia survival has improved at all ages over the last 25 years,
the greatest improvements have been at the youngest ages: at age
0-4 years, 5-year survival increased from 21.0% for cases incident
in 1968-72 to 74.3% for cases incident in 1983-87, compared
with a rise from 12.5% to 22.5% at age 35-44 years, and from
12.0% to 16.9% at age 65-74 years (Black et al, 1993).
The increase in childhood leukaemia incidence is of concern.
Registration completeness for this tumour has been particularly
good (Glass et al, 1987), so the rise does not appear to be attribut-
able to better registration. In other countries, data have provided
limited evidence for an increase in acute lymphocytic leukaemia
(ALL), at least at young childhood ages, which, 'if real, seems to
have occurred at different times in different countries and to be
small' (Draper et al, 1994). The known causes of childhood
leukaemia - Down's syndrome and certain other rarer chromo-
some abnormalities, and ionizing radiation, probably including
intrauterine irradiation - would not explain the increase. The
average annual radiation dose in the UK from weapons fallout
increased from the late 1940s, when the first nuclear weapon
explosion in the atmosphere took place, to the mid-1960s, and
decreased thereafter when the test ban treaty was implemented
(Hughes et al, 1989). The levels increased slightly again after the
1986 Chernobyl accident. As noted previously for Scottish data up
to 1984 (Darby and Doll, 1987), there has been no relationship
between leukaemia trends and levels offallout. It has been hypoth-
esized that population mixing leading to increased infection rates
may be a cause of childhood leukaemia, and raised rates have been
found in certain parts of Scotland where there has been a high level
of population mixing associated with the North Sea oil industry
(Kinlen et al, 1993). It is not clear, however, whether population
mixing has increased in Scotland overall, as a potential explana-
tion for national trends in childhood leukaemia.
Cancer of unspecified primary site (Figure 27)
Mortality ascribed to cancer of unspecified site has increased
greatly at all ages, but especially at older ages since 1970-74. In
1953-54, unspecified malignancies constituted 0.7% of all cancer
deaths (excluding non-melanoma skin cancer) at age 15-84 years,
butby 1990-93 this had risen to 7.5%. Incidence rates forcancer of
unspecified site have also increased at older ages, but not as greatly
as mortality. Unspecified site malignancies constituted 3.4% of all
cancers other than non-melanoma skin cancer registered incident at
age 15-84 years in 1960-64 and 5.1% in the late 1980s.
One artefact affecting cancer of unspecified site trends has
already been discussed (see p. 3): a temporary increase in registra-
tions in 1966-67. As well as this artefact, there has been a back-
ground continuing increase in rates of cancer of unspecified site.
This might reflect a tendency toward poorer specification of site of
cancers on cancer registrations and death certificates, or toward
less intensive investigation of primary cancer site in persons with
terminal cancer of unknown origin. Autopsy rates have decreased
in Scotland since 1965 (see p. 10), but by a far smaller proportion
than the increase in cancer of unspecified site. Changes in the
procedure for 'medical enquiry' (see p. 3) to certifiers when the
cause described on a death certificate is imprecise could alter rates
for imprecise cause categories, especially cancer of unspecified
site, but no substantial changes to the procedure have occurred, at
least since the early 1970s. Although it is possible that some of the
increase in cancers of unspecified site might have been due to an
increase in the incidence of cancers that metastasize early and
aggressively, the rapidity of the change in rates, especially for
mortality, suggests that it must mainly have been an artefact. The
much larger rate of unspecified site cancer mortality than inci-
dence in recent years also argues that much of the mortality
increase is artefactual.
CONCLUSIONS
Cancer mortality in Scotland has been high, with the greatest rates of
lung cancer in the world and almost the greatest breast cancer rates.
As Figure 28 shows, these two cancers dominate Scottish cancer
mortality and incidence. It is encouraging, however, that for lung
cancer in men and breast cancer in women the secular trend has now
turned downward, and for lung cancer in women, although rates are
continuing to rise, there is a decreasing trend on a cohort basis, and
therefore secular rates should turn down in the longer term.
At young ages the decreasing trends in mortality from testicular
and ovarian cancers, Hodgkin's disease and leukaemia are an
encouraging result of advances in treatment. The increases in
incidence of several cancers - upper aerodigestive tract cancers in
men, melanoma, cervical cancer, testicular cancer, NHL and child-
hood leukaemia - however are of concern, although the recent
cessation ofrise in melanoma mortality and downturn in NHL and
cervical cancer incidence, on a cohort basis, give room for opti-
mism on future secular trends of these. The increasing rates
emphasize the need for preventive actions for known risk factors,
such as alcohol and tobacco use in relation to upper aerodigestive
tract cancers, and for aetiological study especially ofthose cancers
that are increasing for unknown reasons.
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